Clinical Trial Update: A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial is evaluating the addition of cabozantinib to chemotherapy for newly diagnosed osteosarcoma, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: High Grade Osteosarcoma, Localized Osteosarcoma | Phase 2, Phase 3 | Status: RECRUITING